2 years ago

Biogen Quits Controversial Alzheimer's Drug Aduhelm

WSJ
2 years ago

Biogen plans to shut down its controversial Alzheimer's drug Aduhelm

The Independent
Aduhelm Biogen Biogen Quits Controversial Alzheimer's

←Top Latest Headlines